Type I Diabetes: Research Efforts For Faster Acting Treatments
Insulin is necessary for the body
to be able to use sugar. A diagnosis of type
1 diabetes means that your body is no longer producing insulin. Current
treatments require patients to inject insulin at least 30 minutes prior to
eating, which means that they must follow a strict and regimented dietary
schedule. While we have come a long way in the management of Type 1 diabetes,
scientists are working hard to develop even better treatments.
One such potential advancement is
faster-acting insulin treatments. Faster-acting, or “meal-time”, insulin
treatments would mimic normal pancreatic function, giving patients more
flexibility in when they administer insulin and, therefore, when they can eat.
Additionally, faster-acting insulin could help reduce hypoglycemic episodes,
which can lead to severe complications. Lastly, advances in faster-acting
insulin treatments could help accelerate the development of an artificial
pancreas, a solution, which could eventually cure diabetes.
Here at Medical Research Group of
Central Florida, we are participating in these efforts to develop new,
faster-acting insulin treatments, and are looking for research volunteers with
Type 1 diabetes. Research volunteers will be compensated for their time and
travel. Most importantly, research volunteers will help the advancement of type
I diabetes treatment.
Please contact us if you or your
loved one has Type 1 diabetes and might be interested.